<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2023 (4) TMI 1254 - ITAT HYDERABAD</title>
    <link>https://www.taxtmi.com/caselaws?id=310200</link>
    <description>The Tribunal held that a corporate guarantee furnished by the assessee for its AE constituted an &quot;international transaction&quot; under s.92B, as the statutory Explanation expressly includes guarantees; accordingly, the TP adjustment on this count was sustainable in principle. On ALP, it rejected comparison with bank charges paid by the assessee, holding a third party would not assume comparable risk; following co-ordinate bench precedent, it restricted the guarantee commission adjustment to 0.5% of the guaranteed amount. On interest on AE receivables, it directed computation of notional interest at 6% on receivables outstanding beyond 60 days, thereby sustaining adjustment on that basis. On s.35(2AB), it allowed weighted deduction for clinical trial expenditure outside approved facilities, since Form 3CL approval covered such spend.</description>
    <language>en-us</language>
    <pubDate>Thu, 27 Apr 2023 00:00:00 +0530</pubDate>
    <lastBuildDate>Mon, 05 Jan 2026 12:26:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=728803" rel="self" type="application/rss+xml"/>
    <item>
      <title>2023 (4) TMI 1254 - ITAT HYDERABAD</title>
      <link>https://www.taxtmi.com/caselaws?id=310200</link>
      <description>The Tribunal held that a corporate guarantee furnished by the assessee for its AE constituted an &quot;international transaction&quot; under s.92B, as the statutory Explanation expressly includes guarantees; accordingly, the TP adjustment on this count was sustainable in principle. On ALP, it rejected comparison with bank charges paid by the assessee, holding a third party would not assume comparable risk; following co-ordinate bench precedent, it restricted the guarantee commission adjustment to 0.5% of the guaranteed amount. On interest on AE receivables, it directed computation of notional interest at 6% on receivables outstanding beyond 60 days, thereby sustaining adjustment on that basis. On s.35(2AB), it allowed weighted deduction for clinical trial expenditure outside approved facilities, since Form 3CL approval covered such spend.</description>
      <category>Case-Laws</category>
      <law>Income Tax</law>
      <pubDate>Thu, 27 Apr 2023 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=310200</guid>
    </item>
  </channel>
</rss>